Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/17/25 17:22 | 9/8/25 | NAMS | Health | Drug | Pharmaceutical Preparations | Topper James N | CA | D | 4 | P.m | 128 | 20.72 | 0 | 6 | 0 | 6,830 | I | |||||||||||||||
9/10/25 17:39 | 9/9/25 | NAMS | Health | Drug | Pharmaceutical Preparations | Kooij Louise Frederika | P7 | O | Chief Ac | 5 | M.d | 6,033 | 17.52 | 0 | 344 | 33 | D | |||||||||||||||
9/10/25 17:39 | 9/9/25 | NAMS | Health | Drug | Pharmaceutical Preparations | Kooij Louise Frederika | P7 | O | Chief Ac | 5 | S.d | -6,033 | 17.52 | 0 | -344 | 33 | D | |||||||||||||||
8/25/25 17:04 | 8/21/25 | NAMS | Health | Drug | Pharmaceutical Preparations | Kastelein Johannes Jacob Pieter | P7 | DO | Chief Sc | 1 | S.m | -2,472 | 24.72 | 0 | -100 | 69 | I | |||||||||||||||
7/17/25 17:19 | 7/15/25 | NAMS | Health | Drug | Pharmaceutical Preparations | Kling Douglas F | P7 | O | COO | 2 | M.dm | 3,172 | 16.08 | 0 | 197 | 44 | D | |||||||||||||||
7/17/25 17:19 | 7/15/25 | NAMS | Health | Drug | Pharmaceutical Preparations | Kling Douglas F | P7 | O | COO | 2 | S.dm | -3,172 | 16.08 | 0 | -197 | 44 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |